Bombay Super Hybrid Seeds Ltd

As of 17-Nov, Bombay Super Hybrid Seeds Ltd's stock price is Rs 116.22, down 0.8%, and has significantly underperformed with a 4.83% drop over the past week. The stock is near its 52-week low and trading below all moving averages, reflecting bearish trends and concerns about its valuation amid declining profits.

Bombay Super Hyb has shown consistent growth in net sales and profitability, with net sales increasing from 103.25 Cr in March 2020 to 358.76 Cr in March 2025. Despite recent challenges in cash flow, the company has improved its operating profit and profit before tax significantly during this period.

Bombay Super Hybrid Seeds' Q2 FY26 results show a year-on-year sales decline of 4.82% to ₹26.85 crores, with a significant sequential drop of 82.44%. However, the company maintained profitability with a net profit of ₹2.24 crores, an 8.21% increase year-on-year, indicating resilience despite seasonal challenges.

As of 10-Oct, Bombay Super Hybrid Seeds Ltd's stock price is declining at 123.17, down 1.13%, and has underperformed its sector and the broader market significantly. Despite long-term growth, the stock faces challenges such as high valuation and lack of domestic mutual fund investment, indicating low confidence in its current price.

As of September 26, 2025, Bombay Super Hyb is considered expensive and overvalued with a PE ratio of 50.07, significantly higher than its peers, and has underperformed with a year-to-date return of -15.1%.

As of September 26, 2025, Bombay Super Hyb is considered overvalued with a PE ratio of 50.07 and an EV to EBITDA of 42.66, significantly higher than some peers, and has underperformed the Sensex with a return of -24.22%.

As of September 26, 2025, Bombay Super Hyb is considered overvalued with high valuation ratios, including a PE of 50.07, and has underperformed the Sensex with a year-to-date return of -15.1%.

As of September 25, 2025, Bombay Super Hyb is considered very expensive and overvalued with a PE ratio of 51.63 and an EV to EBITDA of 43.91, significantly higher than peers like Jain Irrigation and Indo US Bio-Tech, and has underperformed the Sensex year-to-date with a decline of 12.45%.

As of 23-Sep, Bombay Super Hybrid Seeds Ltd's stock price is 129.84, reflecting a slight decline and trading below key moving averages, indicating a bearish trend. Despite strong long-term growth, the stock's high valuation and lack of investor confidence suggest it may not be a favorable investment currently.

As of 22-Sep, Bombay Super Hybrid Seeds Ltd's stock price is declining at 129.86, reflecting a short-term underperformance with significant losses over the past month. Despite strong long-term growth indicators, the stock's high valuation and lack of mutual fund investment suggest investor caution.

As of 19-Sep, Bombay Super Hybrid Seeds Ltd's stock price is declining at 130.13, down 1.35%, and has underperformed its sector. Despite a strong long-term growth rate, the stock's high valuation and lack of mutual fund investment indicate investor caution.

As of September 15, 2025, Bombay Super Hyb is considered expensive and overvalued with a PE ratio of 51.52 and an EV to EBITDA of 43.83, despite a slight improvement in its valuation outlook, especially when compared to peers like Jain Irrigation and Indo US Bio-Tech, and it has underperformed with a year-to-date return of -12.68%.

Bombay Super Hybrid Seeds has adjusted its valuation, with a PE ratio of 51.52 and a price-to-book value of 13.57. The company shows strong profitability metrics, including a 26.33% ROE. Despite recent stock fluctuations and a year-to-date return of -12.68%, it remains competitive in the agricultural sector.

Bombay Super Hybrid Seeds has adjusted its market valuation, with a P/E ratio of 51.52 and a price-to-book value of 13.57. The company has shown varied performance against the Sensex, achieving significant long-term growth with a 1416.26% return over five years, contrasting with its peer Jain Irrigation.

As of September 11, 2025, Bombay Super Hyb is considered very expensive and overvalued due to its high PE ratio of 51.81, an EV to EBITDA of 44.05, and a poor performance of -26.88% over the past year compared to the Sensex's gain of 0.35%.

As of September 9, 2025, Bombay Super Hyb is considered overvalued with high valuation ratios, including a PE ratio of 50.97, and has underperformed with a year-to-date stock return of -14.19%, compared to the Sensex's 5.18%.